Cytokinetics
CYTK
$65.34
Share price
0.83%
Change (1 day)
72.58%
Change (1 year)
Categories
Cytokinetics (CYTK) - Total assets
Total assets on the balance sheet as of December 2023 : $0.82 B
According to Cytokinetics 's latest financial reports the company's total assets are $0.82 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Cytokinetics - Total assets on balance sheet (from 2003 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.82 B | -18.77% |
| 2022-12-31 | $1.01 B | 20.62% |
| 2021-12-31 | $0.84 B | 57.61% |
| 2020-12-31 | $0.53 B | 84.19% |
| 2019-12-31 | $0.28 B | 37.24% |
| 2018-12-31 | $0.21 B | -28.37% |
| 2017-12-31 | $0.29 B | 73.27% |
| 2016-12-31 | $0.17 B | 47.65% |
| 2015-12-31 | $0.11 B | -13.33% |
| 2014-12-31 | $0.13 B | 59.84% |
| 2013-12-31 | $83.18 M | 7.27% |
| 2012-12-31 | $77.55 M | 46.95% |
| 2011-12-31 | $52.77 M | -32.34% |
| 2010-12-31 | $77.99 M | -36.38% |
| 2009-12-31 | $0.12 B | 40.19% |
| 2008-12-31 | $87.45 M | -43.71% |
| 2007-12-31 | $0.15 B | -8.34% |
| 2006-12-31 | $0.16 B | 85.34% |
| 2005-12-31 | $91.46 M | -28.6% |
| 2004-12-31 | $0.12 B | 103.75% |
| 2003-12-31 | $62.87 M | 11.94% |
| 2002-12-31 | $56.16 M | -28.92% |
| 2001-12-31 | $79.01 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $97.15 B | 11,686.01% | 🇺🇸 USA |
 Trevena TRVN | $45.13 M | -94.52% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | $0.78 B | -4.50% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | $0.36 B | -55.56% | 🇺🇸 USA |
 Array Technologies ARRY | $1.70 B | 107.05% | 🇺🇸 USA |